Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

September 2022; Volume 42,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abe, MARINA

    1. You have access
      Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
      SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA and TSUKASA BABA
      Anticancer Research September 2022, 42 (9) 4603-4610; DOI: https://doi.org/10.21873/anticanres.15964
  2. Ahn, JAEYOUNG

    1. You have access
      Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Among Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast Cancer
      JEONGEUN DO, JINAH CHU, JAEYOUNG AHN, GO EUN BAE, SANG HWA LEE, HYUN-SOO KIM and SUNG-IM DO
      Anticancer Research September 2022, 42 (9) 4453-4460; DOI: https://doi.org/10.21873/anticanres.15945
  3. Aida, TAKESHI

    1. You have access
      Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
      SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA and TSUKASA BABA
      Anticancer Research September 2022, 42 (9) 4603-4610; DOI: https://doi.org/10.21873/anticanres.15964
  4. Ajisawa, KANAE

    1. You have access
      Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer
      HIRONORI FUJII, SHIORI SADAKA, KANAE AJISAWA, NAOKI OKUMURA, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, ITARU YASUFUKU, KOICHI OHATA, RYO KOBAYASHI, YOSHIHIRO TANAKA, HIDEKI HAYASHI and AKIO SUZUKI
      Anticancer Research September 2022, 42 (9) 4581-4588; DOI: https://doi.org/10.21873/anticanres.15961
  5. Akiyama, YASUTO

    1. Open Access
      Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence
      KAZUAKI YASUI, RYOTA KONDOU, HARUO MIYATA, AKIRA IIZUKA, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KEIICHI OHSHIMA, KENICHI URAKAMI, KOJI MURAMATSU, TAKASHI SUGINO, KEN YAMAGUCHI, HIROFUMI OGAWA, TSUYOSHI ONOE, HIDEYUKI HARADA, HIROFUMI ASAKURA, SHIGEYUKI MURAYAMA, TETSUO NISHIMURA, SEIYA GOTO, SHINICHI OKADA, TAKASHI MUKAIGAWA, SATOSHI HAMAUCHI, TOMOYA YOKOTA, YUSUKE ONOZAWA and YASUTO AKIYAMA
      Anticancer Research September 2022, 42 (9) 4417-4428; DOI: https://doi.org/10.21873/anticanres.15942
  6. Almeida, RENATA SANCHES

    1. You have access
      Genetic and Transcriptional Analysis of 8q24.21 Cluster in Gastric Cancer
      BRUNNO SANTOS PEREIRA, FERNANDA WISNIESKI, DANIELLE QUEIROZ CALCAGNO, LEONARDO CAIRES SANTOS, CAROLINA OLIVEIRA GIGEK, ELIZABETH SUCHI CHEN, LUCAS TREVIZANI RASMUSSEN, SPENCER LUIZ MARQUES PAYÃO, RENATA SANCHES ALMEIDA, CAMILA ALBUQUERQUE PINTO, BRUNO TAKAO REAL KARIA, RICARDO ARTIGIANI, SAMIA DEMACHKI, PAULO PIMENTEL ASSUMPÇÃO, LAERCIO GOMES LOURENÇO, CARLOS HARUO ARASAKI, ROMMEL RODRÍGUEZ BURBANO, MARIANA FERREIRA LEAL and MARILIA ARRUDA CARDOSO SMITH
      Anticancer Research September 2022, 42 (9) 4381-4394; DOI: https://doi.org/10.21873/anticanres.15938
  7. Alzahrani, NAYEF

    1. You have access
      Comparison of Microwave and Radiofrequency Ablation in the Treatment of Pulmonary Metastasis of Colorectal Cancer
      CHARIS TAN, OLIVER M. FISHER, LINNA HUANG, NAYEF ALZAHRANI, WINSTON LIAUW, DEREK GLENN and DAVID L. MORRIS
      Anticancer Research September 2022, 42 (9) 4563-4571; DOI: https://doi.org/10.21873/anticanres.15959
  8. Aoyama, TORU

    1. You have access
      Clinical Impact of Surgical Sarcopenia on Long-term Survival
      KEISUKE KOMORI, KAZUKI KANO, TORU AOYAMA, KENTARO HARA, SHINSUKE NAGASAWA, MASATO NAKAZONO, YOTA SHIMODA, YUKIO MAEZAWA, YUTA KUMAZU, TAIICHI KAWABE, MASAKATSU NUMATA, TSUTOMU HAYASHI, TAKANOBU YAMADA, HIROSHI TAMAGAWA, TSUTOMU SATO, HARUHIKO CHO, NORIO YUKAWA, YASUSHI RINO, TAKAKI YOSHIKAWA, TAKASHI OGATA and TAKASHI OSHIMA
      Anticancer Research September 2022, 42 (9) 4545-4552; DOI: https://doi.org/10.21873/anticanres.15957
  9. Apostolidis, SAVVAS

    1. Open Access
      Applicability of a Host-mediated In Vivo/In Vitro Model in Screening for the Carcinogenic Potential of Chemicals
      KATHRIN SCHLATTERER, ANOOSH ESMAEILI, THOMAS MASSA, SAVVAS APOSTOLIDIS and PRAKASH CHANDRA
      Anticancer Research September 2022, 42 (9) 4199-4206; DOI: https://doi.org/10.21873/anticanres.15920
  10. Arakane, TORU

    1. Open Access
      Verification of A New Filter for Isolation of Circulating Tumor Cells by Only Blood Filtration
      KOHEI MORITA, NORIYOSHI SAWABATA, SHIGENOBU TATSUMI, TOMOMI FUJII, TAKASHI NISHIKAWA, TAKESHI KAWAGUCHI, TORU ARAKANE, YOSHIAKI TOMINAGA, HIROKAZU SAKAGUCHI, TARO KOBAYASHI, SHIGETO HONTSU, YOSHIFUMI YAMAMOTO, NOBUHIRO FUJIOKA, NORIKO OUJI-SAGESHIMA, TOSHIHIRO ITO and CHIHO OHBAYASHI
      Anticancer Research September 2022, 42 (9) 4305-4310; DOI: https://doi.org/10.21873/anticanres.15930
« Previous (Pages : 1 2 3 4 5 6 ... 39) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (9)
Anticancer Research
Vol. 42, Issue 9
September 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Establishment of Cytotoxic and Non-cytotoxic NK-92 Cell Clones – Evaluation of Their Function as Target Cells
  • Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study
  • An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line
  • Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells
  • Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire